Biosun Pharma Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • IPO Registration

  • Employees
  • 156

Employees

  • Latest Deal Type
  • IPO
  • (Announced)

  • Investors
  • 15

Biosun Pharma General Information

Description

Developer of pharmaceuticals designed for oncology, autoimmunity, inflammation field. The company focuses on molecular targeting and antibody drug development, enabling doctors to provide with advanced drugs with patients.

Contact Information

Website
www.biosunpharma.com
Ownership Status
In IPO Registration
Financing Status
Venture Capital-Backed
Corporate Office
  • Unit 2, Building 9, No. 2069 Jinchang Road, Liangzhu Street
  • Yuhang District
  • Hangzhou, Zhejiang 311112
  • China
+86 0571
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Unit 2, Building 9, No. 2069 Jinchang Road, Liangzhu Street
  • Yuhang District
  • Hangzhou, Zhejiang 311112
  • China
+86 0571

Biosun Pharma Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Biosun Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. IPO 22-Jan-2026 Announced Generating Revenue
7. Later Stage VC (Series C1) 28-Nov-2025 Completed Generating Revenue
6. Later Stage VC (Series BBB) 18-Aug-2025 Completed Generating Revenue
5. Early Stage VC (Series BB) 30-May-2024 Completed Clinical Trials - Phase 3
4. Early Stage VC (Series B3) 16-Mar-2024 Completed Clinical Trials - Phase 3
3. Early Stage VC (Series B2) 12-Oct-2023 Completed Clinical Trials - Phase 3
2. Early Stage VC (Series B1) 16-Dec-2022 $28.6M $50.5M Completed Clinical Trials - Phase 2
1. Early Stage VC (Series A) 18-Dec-2020 $21.9M $21.9M Completed Pre-Clinical Trials
To view Biosun Pharma’s complete valuation and funding history, request access »

Biosun Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of pharmaceuticals designed for oncology, autoimmunity, inflammation field. The company focuses on molecular t
Drug Discovery
Hangzhou, China
156 As of 2026

Kunshan, China
 

Wilmington, DE
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Biosun Pharma Competitors (2)

One of Biosun Pharma’s 2 competitors is Zelgen, a Formerly VC-backed company based in Kunshan, China.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Zelgen Formerly VC-backed Kunshan, China
Incyte Formerly VC-backed Wilmington, DE
You’re viewing 2 of 2 competitors. Get the full list »

Biosun Pharma Patents

  • 39

    Total Documents Applications and Grants

  • Total Patents Families

  • 19

    Granted

  • 7

    Pending

  • Expiring in next 12 mo

Biosun Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026158546-A1 Vav1 degrader Pending 24-Jan-2025
WO-2026067706-A1 Keap1 modulator Pending 30-Sep-2024
WO-2026002032-A1 Pim kinase inhibitor Pending 25-Jun-2024
EP-4800016-A1 Mettl3 inhibitor Pending 26-Oct-2023
WO-2025087365-A1 Mettl3 inhibitor Inactive 26-Oct-2023 C07D487/04
To view Biosun Pharma’s complete patent history, request access »

Biosun Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biosun Pharma Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds
Hangzhou Yuhang State-owned Capital Investment and Operation Group Government Minority
Beijing Shengshi Hongming Investment Fund Management Fund of Funds Minority
Hyfinity Investments Growth/Expansion Minority
Hainan Sanya Huixian Private Equity Fund Management Venture Capital Minority
Zhejiang Huarui Holdings Growth/Expansion Minority
You’re viewing 5 of 15 investors. Get the full list »

Ready to get started?

Request a free trial

Biosun Pharma FAQs

  • When was Biosun Pharma founded?

    Biosun Pharma was founded in 2020.

  • Where is Biosun Pharma headquartered?

    Biosun Pharma is headquartered in Hangzhou, China.

  • What is the size of Biosun Pharma?

    Biosun Pharma has 156 total employees.

  • What industry is Biosun Pharma in?

    Biosun Pharma’s primary industry is Drug Discovery.

  • Is Biosun Pharma a private or public company?

    Biosun Pharma is a Private company.

  • What is Biosun Pharma’s current revenue?

    The current revenue for Biosun Pharma is .

  • How much funding has Biosun Pharma raised over time?

    Biosun Pharma has raised $114M.

  • Who are Biosun Pharma’s investors?

    Hangzhou Yuhang State-owned Capital Investment and Operation Group, Beijing Shengshi Hongming Investment Fund Management, Hyfinity Investments, Hainan Sanya Huixian Private Equity Fund Management, and Zhejiang Huarui Holdings are 5 of 15 investors who have invested in Biosun Pharma.

  • Who are Biosun Pharma’s competitors?

    Zelgen and Incyte are competitors of Biosun Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process